Topic: Eli Lilly

South Korean pharmaceutical company Celltrion announced that its antibody COVID-19 drug Rekirona is safe and effective after global clinical trials.

The S&P 500 hit a record closing high of 4,239.18 on Thursday as investors largely shrugged off a Bureau of Labor Statistics report detailing rising inflation.

Eli Lilly said Friday it's asked federal regulators to revoke emergency use authorization for lone use of its COVID-19 antibody bamlanivimab, as it develops a combination therapy with the drug it says is more effective.

Pharma giant GlaxoSmithKline announced Friday that it has asked U.S. regulators to approve a new antibody treatment for COVID-19 it's been testing.

Daily insulin jabs can be the bane of existence for people who live with type 2 diabetes, but an investigational once-weekly insulin shot may be a game changer for these folks.

Pharma company Eli Lilly said Wednesday that a late-stage study shows that a two-drug antibody cocktail treatment significantly reduces coronavirus-related hospitalizations and deaths in high-risk patients.

For the third day in a row, new COVID-19 cases in the United States have totaled fewer than 100,000 -- but new deaths once again spiked, according to updated data Wednesday.

The U.S. Food and Drug Administration on Tuesday authorized emergency use of a monoclonal antibody treatment for mild to moderate COVID-19 illness in adults and most youth.

Drugmaker Eli Lilly said Tuesday it has replaced its chief financial officer after an investigation found that he'd had inappropriate communications with company employees.

Drugmaker Eli Lilly says it has an antibody cocktail that has proven to reduce hospitalizations and deaths for high-risk patients with COVID-19, by as much as 70%.